49 related articles for article (PubMed ID: 7890748)
1. A camptothecin-resistant DNA topoisomerase I mutant exhibits altered sensitivities to other DNA topoisomerase poisons.
Knab AM; Fertala J; Bjornsti MA
J Biol Chem; 1995 Mar; 270(11):6141-8. PubMed ID: 7890748
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of recombinant Pneumocystis carinii topoisomerase I: differential interactions with human topoisomerase I poisons and pentamidine.
van Dross RT; Sanders MM
Antimicrob Agents Chemother; 2002 Jul; 46(7):2145-54. PubMed ID: 12069967
[TBL] [Abstract][Full Text] [Related]
3. A Yeast-Based Screening System for Differential Identification of Poisons and Suppressors of Human Topoisomerase I.
Seddek A; Madeira C; Annamalai T; Mederos C; Tiwari PB; Welch AZ; Tse-Dinh YC
Front Biosci (Landmark Ed); 2022 Mar; 27(3):93. PubMed ID: 35345325
[TBL] [Abstract][Full Text] [Related]
4. A human topoisomerase I cleavage complex is recognized by an additional human topisomerase I molecule in vitro.
Søe K; Dianov G; Nasheuer HP; Bohr VA; Grosse F; Stevnsner T
Nucleic Acids Res; 2001 Aug; 29(15):3195-203. PubMed ID: 11470877
[TBL] [Abstract][Full Text] [Related]
5. Topoisomerase I-mediated DNA cleavage induced by the minor groove-directed binding of bibenzimidazoles to a distal site.
Khan QA; Pilch DS
J Mol Biol; 2007 Jan; 365(3):561-9. PubMed ID: 17095016
[TBL] [Abstract][Full Text] [Related]
6. Induction of topoisomerase I cleavage complexes by 1-beta -D-arabinofuranosylcytosine (ara-C) in vitro and in ara-C-treated cells.
Pourquier P; Takebayashi Y; Urasaki Y; Gioffre C; Kohlhagen G; Pommier Y
Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1885-90. PubMed ID: 10677551
[TBL] [Abstract][Full Text] [Related]
7. Position- and orientation-specific enhancement of topoisomerase I cleavage complexes by triplex DNA structures.
Antony S; Arimondo PB; Sun JS; Pommier Y
Nucleic Acids Res; 2004; 32(17):5163-73. PubMed ID: 15469908
[TBL] [Abstract][Full Text] [Related]
8. Mutagenic processing of ribonucleotides in DNA by yeast topoisomerase I.
Kim N; Huang SN; Williams JS; Li YC; Clark AB; Cho JE; Kunkel TA; Pommier Y; Jinks-Robertson S
Science; 2011 Jun; 332(6037):1561-4. PubMed ID: 21700875
[TBL] [Abstract][Full Text] [Related]
9. CFS-1686 causes cell cycle arrest at intra-S phase by interference of interaction of topoisomerase 1 with DNA.
Lin RW; Yang CN; Ku S; Ho CJ; Huang SB; Yang MC; Chang HW; Lin CM; Hwang J; Chen YL; Tzeng CC; Wang C
PLoS One; 2014; 9(12):e113832. PubMed ID: 25460368
[TBL] [Abstract][Full Text] [Related]
10. Camptothecin structure simplification elaborated new imidazo[2,1-b]quinazoline derivative as a human topoisomerase I inhibitor with efficacy against bone cancer cells and colon adenocarcinoma.
Khodair AI; El-Hallouty SM; Cagle-White B; Abdel Aziz MH; Hanafy MK; Mowafy S; Hamdy NM; Kassab SE
Eur J Med Chem; 2024 Feb; 265():116049. PubMed ID: 38185054
[TBL] [Abstract][Full Text] [Related]
11. Antisense transcripts enhanced by camptothecin at divergent CpG-island promoters associated with bursts of topoisomerase I-DNA cleavage complex and R-loop formation.
Marinello J; Chillemi G; Bueno S; Manzo SG; Capranico G
Nucleic Acids Res; 2013 Dec; 41(22):10110-23. PubMed ID: 23999093
[TBL] [Abstract][Full Text] [Related]
12. A novel DNA topoisomerase I inhibitor with different mechanism from camptothecin induces G2/M phase cell cycle arrest to K562 cells.
Wu N; Wu XW; Agama K; Pommier Y; Du J; Li D; Gu LQ; Huang ZS; An LK
Biochemistry; 2010 Nov; 49(47):10131-6. PubMed ID: 21033700
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Camptothecin-induced Genomic Changes in the Camptothecin-resistant T-ALL-derived Cell Line CPT-K5.
Kjeldsen E; Nielsen CJF; Roy A; Tesauro C; Jakobsen AK; Stougaard M; Knudsen BR
Cancer Genomics Proteomics; 2018; 15(2):91-114. PubMed ID: 29496689
[TBL] [Abstract][Full Text] [Related]
14. A simplified and easy-to-use HIP HOP assay provides insights into chalcone antifungal mechanisms of action.
Prescott TAK; Anaissi-Afonso L; Fox KR; Maxwell A; Panaretou B; Machín F
FEBS Lett; 2022 Dec; 596(23):3087-3102. PubMed ID: 36053795
[TBL] [Abstract][Full Text] [Related]
15. DNA Intercalators Inhibit Eukaryotic Ribosomal RNA Synthesis by Impairing the Initiation of Transcription.
Andrews WJ; Ray S; Panova T; Engel C; Panov KI
Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573394
[TBL] [Abstract][Full Text] [Related]
16. Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations.
Jensen NF; Agama K; Roy A; Smith DH; Pfister TD; Rømer MU; Zhang HL; Doroshow JH; Knudsen BR; Stenvang J; Brünner N; Pommier Y
J Exp Clin Cancer Res; 2016 Mar; 35():56. PubMed ID: 27029323
[TBL] [Abstract][Full Text] [Related]
17. FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2-induced resistance.
Westover D; Ling X; Lam H; Welch J; Jin C; Gongora C; Del Rio M; Wani M; Li F
Mol Cancer; 2015 Apr; 14():92. PubMed ID: 25928015
[TBL] [Abstract][Full Text] [Related]
18. Topoisomerase assays.
Nitiss JL; Soans E; Rogojina A; Seth A; Mishina M
Curr Protoc Pharmacol; 2012 Jun; Chapter 3():Unit 3.3.. PubMed ID: 22684721
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the Saccharomyces cerevisiae hydrolase Ldh1p in lipid homeostasis.
Debelyy MO; Thoms S; Connerth M; Daum G; Erdmann R
Eukaryot Cell; 2011 Jun; 10(6):776-81. PubMed ID: 21478434
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
